Intrathyroid thymic carcinoma: A clinicopathological analysis of 22 cases

Annals of Diagnostic Pathology - Tập 67 - Trang 152221 - 2023
Yanan Gao1, Yi Pan1, Ye Luo1, Runfen Cheng1, Qiongli Zhai1
1Department of Pathology, National Clinical Research Centre for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Centre for Cancer, Tianjin Medical University Cancer Institute and Hospital, Huanhu West Road, Hexi District, Tianjin 300060, China

Tài liệu tham khảo

O. R. Lloyd, 2017 Miyauchi, 1985, Intrathyroidal epithelial thymoma: an entity distinct from squamous cell carcinoma of the thyroid, World J Surg, 9, 128, 10.1007/BF01656263 Chan, 1991, Tumors of the neck showing thymic or related branchial pouch differentiation: a unifying concept, Hum Pathol, 22, 349, 10.1016/0046-8177(91)90083-2 Ishikawa, 2021, Whole exome sequencing and establishment of an organoid culture of the carcinoma showing thymus-like differentiation (CASTLE) of the parotid gland, Virchows Arch, 478, 1149, 10.1007/s00428-020-02981-8 Ardighieri, 2021, Carcinoma showing thymus-like differentiation (CASTLE) arising in the sublingual gland, Int J Surg Pathol, 29, 301, 10.1177/1066896920941604 Yamamoto, 2021, Carcinoma showing thymus-like differentiation (CASTLE) of the salivary gland: report of 2 cases of a hitherto under-recognized extrathyroid counterpart, Pathol Res Pract, 227, 10.1016/j.prp.2021.153646 Baloch, 2022, Overview of the 2022 WHO classification of thyroid neoplasms, Endocr Pathol, 33, 27, 10.1007/s12022-022-09707-3 Tahara, 2020, Identification of recurrent TERT promoter mutations in intrathyroid thymic carcinomas, Endocr Pathol, 31, 274, 10.1007/s12022-020-09635-0 Berezowski, 1996, CD5 immunoreactivity of epithelial cells in thymic carcinoma and CASTLE using paraffin-embedded tissue, Am J Clin Pathol, 106, 483, 10.1093/ajcp/106.4.483 Dorfman, 1998, Intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) exhibits CD5 immunoreactivity: new evidence for thymic differentiation, Histopathology, 32, 104, 10.1046/j.1365-2559.1998.00318.x Ito, 2007, Clinicopathologic significance of intrathyroidal epithelial thymoma/carcinoma showing thymus-like differentiation: a collaborative study with Member Institutes of The Japanese Society of Thyroid Surgery, Am J Clin Pathol, 127, 230, 10.1309/VM7E52B6U9Q729DQ Kakudo, 2013, Intrathyroid epithelial thymoma (ITET) and carcinoma showing thymus-like differentiation (CASTLE): CD5-positive neoplasms mimicking squamous cell carcinoma of the thyroid, Histol Histopathol, 28, 543 Hirokawa, 2013, Intrathyroidal epithelial thymoma/carcinoma showing thymus-like differentiation; comparison with thymic lymphoepithelioma-like carcinoma and a possibility of development from a multipotential stem cell, APMIS, 121, 523, 10.1111/apm.12017 Huang, 2013, Carcinoma showing thymus-like differentiation of the thyroid (CASTLE), Pathol Res Pract, 209, 662, 10.1016/j.prp.2013.06.021 Ge, 2016, Clinical analysis of 82 cases of carcinoma showing thymus-like differentiation of the thyroid, Oncol Lett, 11, 1321, 10.3892/ol.2015.4055 Gurizzan, 2021, Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis, Endocr Relat Cancer, 28, 593, 10.1530/ERC-21-0123 Zheng, 2021, Clinicopathological features of intrathyroid thymic carcinoma, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 43, 42 Bonneville, 2017, Landscape of microsatellite instability across 39 cancer types, JCO Precis Oncol, 2017 Radovich, 2018, The integrated genomic landscape of thymic epithelial tumors, Cancer Cell, 33, 244, 10.1016/j.ccell.2018.01.003 Repetto, 2021, Thymic carcinoma with lynch syndrome or microsatellite instability, a rare entity responsive to immunotherapy, Eur J Cancer, 153, 162, 10.1016/j.ejca.2021.05.029 Li, 2023, Intrathyroid thymic carcinoma: clinicopathological features and whole exome sequencing analysis, Virchows Arch, 482, 813, 10.1007/s00428-023-03536-3 Moreira, 2015, Massively parallel sequencing identifies recurrent mutations in TP53 in thymic carcinoma associated with poor prognosis, J Thorac Oncol, 10, 373, 10.1097/JTO.0000000000000397 Wang, 2015, Thyroid carcinoma showing thymus-like elements: a clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis, Am J Clin Pathol, 143, 223, 10.1309/AJCPB7PS6QHWEFRK Haroon Al Rasheed, 2019, Molecular alterations in thyroid carcinoma, Surg Pathol Clin, 12, 921, 10.1016/j.path.2019.08.002 Pan, 2012, Absence of gene mutations in KIT-positive carcinoma showing thymus-like elements of the thyroid, Hum Pathol, 43, 350, 10.1016/j.humpath.2011.05.003 Veits, 2014, KRAS, EGFR, PDGFR-alpha, KIT and COX-2 status in carcinoma showing thymus-like elements (CASTLE), Diagn Pathol, 9, 116, 10.1186/1746-1596-9-116 Kuroki, 2022, A case of thyroid carcinoma showing thymus-like differentiation with breast cancer susceptibility gene 2 mutation: a case report and literature review, Cureus, 14 Doroshow, 2021, PD-L1 as a biomarker of response to immune-checkpoint inhibitors, Nat Rev Clin Oncol, 18, 345, 10.1038/s41571-021-00473-5 Lorenz, 2019, Pembrolizumab in a patient with a metastatic CASTLE tumor of the parotid, Front Oncol, 9, 734, 10.3389/fonc.2019.00734 Ishii, 2022, Genomic and immune microenvironment profiling in a case of metastatic intrathyroid thymic carcinoma, Clin Case Rep, 10, 10.1002/ccr3.6050 Liang, 2022, Intrathyroidal thymic carcinoma: a retrospective case series study, Ear Nose Throat J